Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid Maintenance in AML Patients in Remission
NCT00957385Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2008
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in acute myeloid leukemia (AML), sponsored by University Health Network. Started Jun 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00957385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957385.